Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FZ828
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,868
Award facts
- Contract value 100% obligated
- $18,868.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $18,868.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on November 14, 2025, with an ultimate completion date of November 17, 2025, carries no set-aside designation and was made without a subcontracting arrangement. DMS Pharmaceutical Group is fulfilling pharmaceutical supply requirements under its recently established Indefinite Delivery Contract (IDC) with the DLA, designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
This delivery order represents one of numerous orders being issued under DMS Pharmaceutical Group's PPV-G GEN V prime vendor contract, which was awarded on November 13, 2025, with a ceiling value of $499,999,999 and an ultimate completion date of December 31, 2036. The broader PPV-G GEN V acquisition strategy, valued at $30.3 billion, establishes multiple regional prime vendor contractors to provide comprehensive pharmaceutical products—including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables—to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's substantial product portfolio and demonstrated delivery capabilities position it as a critical pharmaceutical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DU26FZ828?
SPE2DU26FZ828 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DU26FZ828 worth?
The government has obligated $18,868 on SPE2DU26FZ828.
Is contract SPE2DU26FZ828 an order under another contract?
Yes. SPE2DU26FZ828 is a delivery order under SPE2DU25D9434, an indefinite delivery contract.
Was contract SPE2DU26FZ828 competed?
The extent of competition for SPE2DU26FZ828 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award